Rong Lihttps://orcid.org/0000-0002-4465-3324 1, Miaoqing Hehttps://orcid.org/0000-0001-7116-0982 2,3, Bing Wuhttps://orcid.org/0000-0002-7153-4136 4, Peng Zhanghttps://orcid.org/0000-0001-8071-3729 1, Qinbin Zhanghttps://orcid.org/0000-0002-9772-1511 1, and Yangmei Chenhttps://orcid.org/0000-0002-0560-8299 1
1Department of Neurology, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
2Center for Brain Disorders Research, Capital Medical University, Feng Tai District, Beijing, China
3Beijing Institute for Brain Disorders, Feng Tai District, Beijing, China
4Department of Neurology, First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Neurology, Chongqing, China
Correspondence: Yangmei Chen: <chenym1997@cqmu.edu.cn>
Erratum for: Braz J Med Biol Res | doi: 10.1590/1414-431X20199175 | PMID: 32267308 | PMCID: PMC7162585
On July 7, 2020, the Brazilian Journal of Medical and Biological Research received a request from the first author Rong Li requesting the substitution of Figure 1B, Panels: Rat Hippocampus SAD-B, MAP2, and MERGE because these 3 images had been submitted incorrectly. This modification of Figure 1 does not change the findings of this research. After careful evaluation by the Editors, this erratum is being published.
Figure 1. Brain-specific serine/threonine-protein kinase 1 (SAD-B) is localized in the epileptic brain. A, Immunofluorescence labelling of SAD-B (red), MAP2 (violet), and GFAP (green) in the cortex of patients with temporal lobe epilepsy (TLE) showing that SAD-B was co-localized with MAP2 but not with GFAP. Scale bar: 50 μm (400×). B, Immunofluorescence labelling of SAD-B (red), MAP2 (violet), and GFAP (green) in the CA1 region of the hippocampus or cortex of an epileptic rat showing that SAD-B was co-localized with MAP2, but not with GFAP. Scale bar: 50 μm (400×). White arrows: SAD-B; yellow arrows: GFAP.
